Recombinant TNFRSF4 (Revdofilimab Biosimilar) antibody

Catalog No. ABIN7597945

The Chimeric Chimeric anti-TNFRSF4 (Revdofilimab Biosimilar) antibody is suitable to detect TNFRSF4 (Revdofilimab Biosimilar) in samples from Human.

Quick Overview for Recombinant TNFRSF4 (Revdofilimab Biosimilar) antibody (ABIN7597945)

Target: TNFRSF4 (Revdofilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: Un-conjugated

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Research Grade Revdofilimab Biosimilar Antibody

Specificity: ACT35 antigen, TXGP1L, TAX transcriptionally-activated glycoprotein 1 receptor, Tumor necrosis factor receptor superfamily member 4, TNFRSF4, OX40L receptor, CD134

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.3 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details

Target: TNFRSF4 (Revdofilimab Biosimilar)

Alternative Name: Revdofilimab Biosimilar

Target Type: Biosimilar

Background: ACT35 antigen, TXGP1L, TAX transcriptionally-activated glycoprotein 1 receptor, Tumor necrosis factor receptor superfamily member 4, TNFRSF4, OX40L receptor, CD134

UniProt: P43489